LETTER TO THE EDITOR
Bimekizumab-induced acral pustulovesicular eruption in a patient with psoriatic arthritis
Ryuto Mukaiyama,
Ryuto Mukaiyama
Department of Dermatology, Fukushima Medical University, Fukushima, Japan
Search for more papers by this author Toshiyuki Yamamoto,
Corresponding Author
Toshiyuki Yamamoto
Department of Dermatology, Fukushima Medical University, Fukushima, Japan
Correspondence
Toshiyuki Yamamoto, Department of Dermatology, Fukushima Medical University School of Medicine, 1-Hikarigaoka, Fukushima 960-1295, Japan.
Email: [email protected]
Search for more papers by this author
Ryuto Mukaiyama,
Ryuto Mukaiyama
Department of Dermatology, Fukushima Medical University, Fukushima, Japan
Search for more papers by this author Toshiyuki Yamamoto,
Corresponding Author
Toshiyuki Yamamoto
Department of Dermatology, Fukushima Medical University, Fukushima, Japan
Correspondence
Toshiyuki Yamamoto, Department of Dermatology, Fukushima Medical University School of Medicine, 1-Hikarigaoka, Fukushima 960-1295, Japan.
Email: [email protected]
Search for more papers by this author
First published: 24 September 2024
No abstract is available for this article.
| Filename |
Description |
| jde17468-sup-0001-FigureS1.zipZip archive, 186.6 KB |
Figure S1.
|
Please note: The publisher is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.
REFERENCES
- 1Napolitano M, Megna M, Fabbrocini G, Nisticò SP, Balato N, Dastoli S, et al. Eczematous eruption during anti-interleukin 17 treatment of psoriasis: an emerging condition. Br J Dermatol. 2019; 181: 604–606.
- 2Peera M, Smith A. Palmoplantar pompholyx secondary to interleukin 17A inhibitor therapy for psoriasis: a case series. JAAD Case Rep. 2021; 13: 46–48.
- 3Caldarola G, Pirro F, Stefani AD, Talamonti M, Galluzzo M, D'Adamio S, et al. Clinical and histopathological characterization of eczematous eruptions occurring in course of anti IL-17 treatment: a case series and review of the literature. Exp Opin Biol Ther. 2020; 20: 665–672.
- 4Abreu-Velez AM, Pinto FJ Jr, Howard MS. Dyshidrotic eczema: relevant to the immune response in situ. N Am J Med Sci. 2009; 1: 117–120.
- 5Borowczyk J, Shutova M, Brembilla NC, Boehncke WH. IL-25 (IL-17E) in epithelial immunology and pathophysiology. J Allergy Clin Immunol. 2021; 148: 40–52.
